MHRA
Accord Healthcare launches thalidomide for multiple myeloma treatment
March 23, 2021Manufacturing and Production MHRA, oncology
Accord Healthcare has announced the UK launch of a generic thalidomide, which is used in combination with melphalan and prednisone, …
Lilly’s cancer drug Retsevmo gets UK approval for multiple indications
March 10, 2021Research and Development Cancer, Eli Lilly, MHRA
The MHRA has granted conditional marketing authorisation for Eli Lilly’s Retsevmo (selpercatinib) as monotherapy for a number of cancer indications.
Seagen’s breast cancer drug TUKYSA gets UK approval
February 22, 2021Sales and Marketing Cancer, MHRA, Seagen
The MHRA has granted marketing authorisation in the UK for Seagen’s TUKYSA (tucatinib) in combination with trastuzumab and capecitabine, for …
MHRA grants Promising Innovative Medicine Designation to Sanofi’s RSV drug
January 19, 2021Manufacturing and Production MHRA, Sanofi
The MHRA has granted a Promising Innovative Medicine (PIM) Designation to Sanofi’s nirsevimab, which is being investigated a passive immunisation …
MHRA warns patients with history of significant allergic reactions not to receive Pfizer/BioNTech COVID-19 vaccine
December 9, 2020Research and Development COVID-19, MHRA, UK, Vaccine
While the rolling out of Pfizer and BioNTech’s COVID-19 in the UK this week marked a historic moment in a …
MHRA gives OK to Bavencio for first-line maintenance of advanced bladder cancer via the Early Access to Medicines Scheme
September 3, 2020Sales and Marketing Bavencio, MHRA, Merck, Pfizer, UK, eams, pharma
It has been revealed that Bavencio (avelumab), jointly developed by Merck KGaA and Pfizer, has been approved by the UK …
MHRA designates cenobamate as a Promising Innovative Medicine for treating drug resistant seizures
August 13, 2020Research and Development MHRA, cenobamate, seizures
Arvelle Therapeutics has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has given their anti-seizure medication (cenobamate) …
MHRA launches new pharmacovigilance reporting platform for COVID-19 treatments
May 5, 2020Manufacturing and Production, Research and Development COVID-19, MHRA, UK, coronavirus, pharma
A new online reporting site has been launched by the Medicines and Healthcare products Regulatory Agency’s (MHRA) to track potential …
MHRA expands approval of Dysport for symptomatic treatment of focal spasticity of the upper limbs in paediatric cerebral palsy
January 6, 2020Sales and Marketing Dysport, MHRA, ipsen, pharma
Ipsen has secured an expansion in the UK to the existing label for Dysport (lemborexant), with the Medicines and Healthcare …
Over half of all US/EU regulator warnings issued to Indian and Chinese manufacturers, report finds
August 28, 2019Manufacturing and Production, Research and Development China, India, MHRA, UK, manufacturing, pharma
Concerns have been raised concerning the integrity of the global supply chain after a report from The Pharmaceutical Journal revealed …
Medicines recalled after FMD alert
July 1, 2019Sales and Marketing FMD, MHRA, labels, pharma, recall, supply chain
The MHRA has warned patients that batches of drugs for Parkinson’s, epilepsy and blood clots have been taken out of …
MHRA recall M&A Pharmachem’s paracetamol due to fungal contamination
June 18, 2019Manufacturing and Production Contamination, MHRA, fungal, paracetamol, pharma
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a recall of M&A Pharmachem’s 500mg paracetamol tablets. The …
MHRA warns of congenital malformation risk of neo-mercazole during pregnancy
February 22, 2019Medical Communications, Research and Development MHRA, neo-mercazole, pharma
UK drug watchdog The Medicines and Healthcare products Regulatory Agency (MHRA) has warned of the potential side-effects of Neo-mercazole (carbimazole) …
MHRA issues recall of irbesartan blood pressure meds over carcinogen contamination concerns
January 4, 2019Manufacturing and Production, Medical Communications MHRA, irbesartan, pharma, sartan, valsartan
Following a number of recalls issued in the US and Europe in the latter half of 2018 for the blood …
MHRA Chief to step down in 2019
November 21, 2018Medical Communications, Research and Development MHRA, UK, brexit, pharma
The Medicines and Healthcare products Regulatory Agency (MHRA), the regulator responsible for the efficacy and safety of medicines in the …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
